top of page
Image by National Cancer Institute

Welcome to CME Spark

Home: Welcome

Mission

CME Spark is committed to delivering innovative continuing education to healthcare providers that strengthens their efforts to deliver high-quality patient-centered care.

Home: Text
Senior Female Teacher

About Us

At CME Spark, we develop engaging continuing education courses that help healthcare providers stay current on treatment options, guidelines, and best practices. We know that creative, dynamic content is easier for learners to retain and ultimately affects the quality of care that patients receive. With years of experience in the CME industry, we strive to offer an adaptable approach in an ever-changing medical education environment.

Home: About Us
Empty Classroom

Sign up!

To receive emails featuring our CME offerings, please complete the form below:

Degree
Specialty

Thanks for submitting!

Home: Sales Lead

CME Programs

58IBD 800x450.jpg

Inflammatory Bowel Disease

The introduction of biologics changed systemic treatment paradigms for IBD, which was previously managed with aminosalicylates, corticosteroids, and immunosuppressants. While biologic agents have significantly improved outcomes, not all patients respond or maintain response. These limitations have led to the development of novel small molecule drugs for patients with IBD, which have the benefits of oral administration, short half-life, high volume of distribution, and lack of immunogenicity. Several small-molecule agents such as those targeting Janus kinase (JAK) and sphingosine-1-phosphate (S1P) have recently been approved in ulcerative colitis and are being explored in Crohn’s disease. However, the expanding therapeutic armamentarium makes individualized treatment selection even more complex.


This Patient POV program is an interactive, case-based microlearning activity that allows learners to explore strategies for oral treatment selection and share decision-making in the management of IBD.

NASH 800x450.jpg

Non-Alcoholic Steatohepatitis

Currently, no NASH-specific therapies have been approved by the FDA. Despite NASH being considered an asymptomatic disease, up to half of NASH patients experience burdensome symptoms that negatively impact health-related quality of life. Therefore, early identification, targeted treatment, and a greater understanding of symptom burden are a high unmet need to improve patient outcomes.

Patient POV is an interactive case-based microlearning activity that allows learners to explore strategies for timely and non-invasive NASH diagnosis, guideline-recommended treatment, and emerging data on novel therapies.

PBC 800x450.jpg

Primary Biliary Cholangitis

Case Closed is an interactive case-based microlearning format that allows learners to explore challenging patient cases alongside an expert. The Chair will guide learners through 4 cases on guideline recommendations for first- and second-line treatment selection, monitoring, managing symptom burden, and new data on emerging therapies for PBC.

Screen Shot 2022-10-05 at 5.09.33 PM.png

Colorectal Cancer CME

The molecular heterogeneity of colorectal cancer tumors leads to variability in outcomes, highlighting the need for biomarkers for targeted treatment selection. To address these educational needs, CME Spark has launched this CME-accredited CRC Case Closed program to provide healthcare providers with a microlearning learning experience that focuses on biomarkers to inform selection of targeted and immunotherapies in the management of mCRC. In this activity, Benny Johnson, DO, MD Anderson Cancer Center, discusses the role of biomarkers in patients with metastatic CRC.

bt30jutf8yyx-SBS800x450.jpg

Short Bowel Syndrome CME

CME Spark and the American Gastroenterological Association developed a Case Closed CME program for gastroenterologists and other healthcare providers involved in the care of patients with short bowel syndrome (SBS) to have a case-based learning experience that focuses on guidelines and best practices.

uh0q8rw7l6k9-800x450px_IBS.jpg

Irritable Bowel Syndrome CME

Irritable bowel syndrome (IBS) is one of the most common disorders of gut-brain interaction (DGBI) and has a significant impact on patients and the health care system. Making the correct diagnosis can improve patient care, minimize unnecessary testing, and lead to the most appropriate treatment. In this activity, learners will review 5 IBS cases with Brian E. Lacy, MD, PhD, FACG as he discusses different aspects of patient management including diagnosis, IBS-C and IBS-D treatment, pain management, and improving patient-provider communication.

lnzkjvb4jsg6-UCBanner800x450-2.png

Ulcerative Colitis CME

In collaboration with the American Gastroenterological Association, CME Spark presents a unique CME activity titled, Ulcerative Colitis: Applying Guidelines in Practice. This program features a recorded webcast with a panel of UC experts followed by 3 interactive case studies.

Screen Shot 2022-10-05 at 5.04.40 PM.png

COPD CME

The COPD Visual Toolkit features a discussion between pulmonologist Fernando Martinez, MD, and primary care physician Barbara Yawn, MD. As they review tools for COPD management, Dr. Martinez and Dr. Yawn will discuss COPD cases that are illustrated with whiteboard animations clips to enhance the learning experience. This activity will include an infographic with symptom burden questionnaires, treatment algorithms, and resources for patients.

Home: Press

Contact Us

Questions? Feel free to send us a message!

Home: Text
Home: Instagram
bottom of page